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Background. The FDA approved over-the-counter (OTC) use of vaginal antifungals in 1990. Subsequently, a plethora of OTC
products have become available to women on drugstore shelves. Objectives. The purpose of this study was to determine the avail-
ability of OTC products marketed for the treatment of vaginitis and to determine if their eﬃcacy had been conﬁrmed by published
prospectiverandomizedcontroltrials(RCTs).Materialsandmethods.Theauthorschosefourretaillocationsfrequentedbywomen
seeking vaginitis treatment. All products deemed a viable treatment option were purchased. Results. All intravaginal imidazoles
purchased, regardless of treatment duration or active ingredient, were found to be of proven eﬃcacy. We were unable to ﬁnd an
RCT conﬁrming the eﬀectiveness of vaginal anti-itch creams and homeopathic treatments for vaginitis. Conclusion. 45% of prod-
ucts available to women in the feminine hygiene section of the stores surveyed could not be conﬁrmed to be eﬀective for treating
infectious vaginitis.
Copyright © 2007 Lauren B. Angotti et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Each year, an estimated 10 million health care oﬃce visits
to gynecologists are due to vulvovaginitis [1]. Vulvovagini-
tis refers to a variety of inﬂammatory lower genital tract
disorders that may be secondary to infection, irritation, al-
lergy, or systemic disease. Infectious causes of vulvovagini-
tis include bacterial vaginosis, candidiasis, and trichimoni-
asis; while noninfectious causes include exposure to chem-
icals, allergens, genital atrophy, and trauma. Of the infec-
tious vaginitides, only vulvovaginitis due to Candida oﬀers
over the countermedications forwomen to self diagnose and
treat their condition. These nonprescription antifungals, in-
troduced to the market in 1990, are among the top ten best
selling over-the-counter drugs in the US with annual sales
of approximately $250 million [2]. One survey reports that
73% of women with recurrent vulvovaginitis have resorted
to over-the-counter medications to reduce health care cost
and avoid an expensive oﬃce visit [3]. Further, homeopathic
drug sales were estimated at $201 million in 1995 and have
steadily risen to an estimated 300–450 million in 2003 [3, 4].
This article attempts to clarify the eﬃcacy of the avail-
able over-the-counter options for women seeking self treat-
ment for vaginitis symptoms and further discern which
products are appropriate for treating self-diagnosed yeast
vaginitis.
2. MATERIALS AND METHODS
We visited four common venues frequented by women
in their search for vaginitis treatment; one grocery store,
one drug store, one health food store, and the ubiqui-
tous Wal-mart. We went to the feminine hygiene section
of each store and purchased one of each available prod-
uct that could be considered a treatment option by the
average consumer. All products containing the statement
“cures most vaginal yeast infections” were purchased as
well as any products claiming to “relieve vaginal itching”.
We next conducted a review of the literature, searching for
RCTs evaluating the eﬃcacy of each product. Our search
for published literature included conventional search en-
gines (Pub Med, Ovid, Cochcrane, CINAHL, APC journal
club, Google), and alternative medicine databases (Long-
wood Herbal Taskforce, NCCAM, Natural Medicines Com-
prehensive Database).2 Infectious Diseases in Obstetrics and Gynecology
Table 1: Intra-vaginal Imidazoles. One-day treatments.
Generic name Brand name Dose/duration Cost Eﬃcacy
Tioconazole 6.5% Equate (Wal-Mart) One day $10 High∗
Tioconazole 6.5% Vagistat-1 One day $15 High
Miconazole nitrate2% Monistat-1 1200g/One day $19 High
∗ All listed active ingredients are on the CDC approved treatment list for Candida vaginitis.
High eﬃcacy is equal or greater than 80% cure rate.
Table 2: Intra-vaginal Imidazoles. Three-day treatments.
Generic name Brand name Dose/duration Cost Eﬃcacy
Miconazole nitrate 4% Monistat-3 3 days $15 High∗
Miconazole nitrate Monistat-3 (suppositories) 3 days $17 High
Clotrimazole 2% Eckerd brand generic 3 days 3 days $8 High
Miconazole nitrate 2% Equate (Wal-Mart) 3 days $9 High
∗ All listed active ingredients are on the CDC approved treatment list for Candida vaginitis.
High eﬃcacy is equal or greater than 80% cure rate.
3. RESULTS
The products purchased could be grouped into three cat-
egories: intravaginal imidazoles, vaginal anti-itch creams,
and homeopathic treatments. The prices of these products
ranged from $2–$19. All prices were rounded oﬀ to the
nearest dollar before taxes. The intravaginal imidazoles were
as a whole the more expensive products ranging from $6–
$19, with an average cost of $12. The homeopathic remedies
ranged in price from $4–$13, with an average cost of $8.50.
Finally, the vaginal anti-itch creams range in price from $2–
$6, with an average price of $4.
The intravaginal imidazoles cure more than 80% of
yeast vaginitis [5]. There is no signiﬁcant diﬀerence in ef-
ﬁcacy among the intravaginal imidazoles [5]. Further, a re-
view of ﬁve RCTs found no signiﬁcant diﬀerence in treat-
ment durations of one to fourteen days of imidazole ther-
apy for uncomplicated vulvovaginitis [6]. The CDC recom-
mends that pregnant women use the seven-day treatment
course due to the lower average concentration of medication
[7]. Finally, the one, three, and seven-day regimens all de-
liver the same total dosage of active ingredient; they diﬀer
solely in the number of doses and therefore strength of each
dose.
Our review of the literature failed to reveal studies con-
ﬁrming the eﬃcacy of vaginal anti-itch creams for treatment
of infectious vaginitis. These products may confuse women
seeking self treatment for vaginitis due to their proximity on
the shelves, as well as their claims to “relieve vaginal itching,”
the primary symptom of yeast vaginitis.
WecouldnotlocateanyRCTsprovingtheeﬀectivenessof
any of the homeopathic treatments. Overall, clinical studies
involving any homeopathic remedy have been contradictory.
A study conducted by the National Center for Complemen-
tary and Alternative Medicine concluded: “systemic reviews
have not found homeopathy to be a deﬁnitively proven treat-
ment for any medical condition” [8].
4. DISCUSSION
Despite the introduction of OTC drugs for treatment of vul-
vovaginitis, the costs of health care oﬃce visits to treat this
disorder are still rising, to an estimated of 3.1 billion dollars
by 2014 [1]. This may be due to the fact that women have
proventobeinadequateinselfdiagnosis.Infact,inonestudy
only one third of the women correctly diagnosed themselves
with a yeast vaginitis [9]. Further, women with a previous
clinical diagnosis of Candida infection were not more accu-
rate at identifying their current condition [9].
The most common cause of infectious vulvovaginitis is
bacterial vaginosis which has been found to be twice as
prevalent as yeast vaginitis [10]. While vaginitis was once
thought not to be clinically perilous, there is a mounting
body of evidence linking infectious vaginitis with more se-
rious adverse reproductive outcomes. Infection with bacte-
rial vaginosis and trichomoniasis have been shown to in-
crease one’s risk of acquiring HIV and other STI’s includ-
ing PID, which can lead to infertility [2, 9]. Further, there
has been a positive link between bacterial vaginosis and in-
creasedriskofpretermlabor[5].BValsoincreasesawomen’s
risk of postabortion uterine infection and posthysterectomy
cuﬀ infection [11]. Empowering women to correctly iden-
tify and treat their symptoms with the proper medications
will alleviate their discomfort and prevent adverse outcomes
from lack of recognition of symptoms necessitating a physi-
cian visit.
Since our ﬁndings did not prove any signiﬁcant diﬀer-
ences between brand or formulation of any of the intravagi-
nal imidazoles, women should chose their treatment based
on personal preference. Knowing that these products are
equally eﬀective allows the consumer to base her decision
on price, route of administration, and ease of use. It should
be noted that women with chronic or persistent yeast infec-
tionsarelesslikelytorespondtoshortcoursesoftherapyand
should consult with their doctor about a speciﬁc treatmentLauren B. Angotti et al. 3
Table 3: Intra-vaginal Imidazoles. Seven-day treatments.
Generic name Brand name Dose/duration Cost Eﬃcacy
Miconazole nitrate 2% Monistat-7 7 Days $15 High∗
Clotrimazole 1% Eckerd brand 7 Days $8 High
Micanzole nitrate 2% Equate (Wal-Mart) 7 Days $6 High
∗ All listed active ingredients are on the CDC approved treatment list for Candida vaginitis.
High eﬃcacy is equal or greater than 80% cure rate.
Table 4: Vaginal anti-itch creams.
Brand name Active ingredient Cost Eﬃcacy
Vagisil Original Benzocaine 5%, resocinol 2% $5 Eﬀective as anti-itch only, no eﬃcacy as antifungal
Vagisil Extra-Strength Benzocaine 20%, resocinol 3% $6 Eﬀective as anti-itch only, no eﬃcacy as antifungal
Summers Eve Paramoxine hydrochloride 1%, glycerin 39% $4 Eﬀective as anti-itch only, no eﬃcacy as antifungal
Equate Vaginal Cream Benzocaine 20%, resocinol 3% $2 Eﬀective as anti-itch only, no eﬃcacy as antifungal
Vagi-gard Benzocaine 5%, benzalkonium chloride 13% $4 Eﬀective as anti-itch only, no eﬃcacy as antifungal
Vagi-gard Extra Strength Benzocaine 20%, benzalkonium chloride 13% $4 Eﬀective as anti-itch only, no eﬃcacy as antifungal
Table 5: Homeopathic treatments
Brand name Main ingredient Other ingredients Cost Eﬃcacy
Yeast-Away Borax 14x HPUS Calendula oﬃcinalis 1 x HPUS, Candida albicans 30 x HPUS $13 Unknown
Yeast Guard Pulsatilla 28x Candida Parapoilosis, Candida albicans 28x $8 Unknown
Azo Yeast Tablets Boneset and Mistletoe Leaf 6x Lactobacillus sporogenes $7 Unknown
regimen [5]. They are thereforenot candidates for OTCther-
apy.
Vaginal anti-itch creams are grouped on the shelves
next to the vaginal yeast infection treatments. These prod-
ucts such as Vagisil, Vagi-gard, Summers Eve, and Equate
vaginal cream are marketed to the consumer as anti-itch
creams, making them a seemingly enticing treatment option
for symptomatic relief of pruritis associated with Candida.
These creams utilize ingredients including anesthetics (ben-
zocaine), external analgesics (resorcinol), and anti-pruitics
(hydrocortisone). However, these creams only relieve minor
itching and have no antimicrobial eﬀects. They may mask
symptoms but do not resolve the cause of infection. Women
should be aware that if they purchase these creams they
may experience only temporary alleviation of symptoms and
this may delay appropriate medical treatment. Further, these
creams may act as an irritant in some women and in fact ex-
acerbate their symptoms.
A wide variety of nontraditional therapies have been
touted for their potential to combat yeast infections. The
most commonly cited alternative therapies in a literature
review were yogurt containing live acidophilus, boric acid
tablets, garlic, and tea tree oil. However, our search did not
uncover any OTC products utilizing these ingredients that
bore a label claiming to “cure most vaginal yeast infections.”
Ofthealternativetherapieswidelyavailableover-the-counter
claimingtotreatyeastinfections,homeopathicremediespre-
dominate.
A variety of homeopathic treatments were not only avail-
able at the health food stores, but at least one homeopathic
product was on the shelves at each venue we visited, includ-
ing Eckerd Drug and Wal-Mart. Homeopathic remedies as a
genre were signiﬁcantly less expensive with a mean price of
$3.50 less than the intravaginal imidazoles.
Simplistically, the theory of homeopathy is to adminis-
ter small doses of toxic substances to stimulate the body’s
own immune response. Based on this theory, homeopathic
remedies contain much diluted concentrations of active in-
gredients. Homeopathic products are often so diluted that
they no longer contain even a single molecule of the “ac-
tive” substance [8]. This accounts for the fact that homeo-
pathic substances have little proven beneﬁcial or harmful ef-
fects [8].
The aﬀordability oﬀered by homeopathic treatments is
concerningforthefollowingreasons.Studieshavefoundthat
womenwithrecurrentvaginalyeastinfectionsaremorelikely
to experiment with alternative therapies due to the lower rel-
ative cost and the diﬃculty of obtaining a last minute doc-
tors appointment [1]. An estimated 42% of patients with re-
current vaginal yeast infections have resorted to alternative
therapies [1]. The use of products not proven eﬃcacious or
approved by the CDC may delay treatment of more serious
medical conditions or promote more adverse outcomes.
5. CONCLUSION
Thediscomfortcausedbyvaginitismeritsprompttreatment.
Self-treating allows women to minimize out-of-pocket costs,
and avoid a costly and time consuming visit to their health
care provider. However, choosing a treatment for vaginitis4 Infectious Diseases in Obstetrics and Gynecology
can be cumbersome due to the number of available prod-
ucts, causing the consumer to feel overwhelmed and con-
fused. Most topical agents for treating vulvovaginal candidi-
asis are available OTC, packaged in the one, three, or seven-
da ytr eatments.Thesepr oductsar eofequaleﬃcacy,allowing
the consumer to purchase a treatment based on the ease of
use and price.
Consumersshouldbeawarethatvaginalanti-itchcreams
and homeopathic remedies have not-proven eﬃcacy in any
RTCs and homeopathic treatments likely do not contain
enough “active” substance to merit an eﬀect. The price dis-
crepancy among treatments may lure the consumer towards
treatments that have little or no proven eﬃcacy. The CDC
recommendations for treatment of vaginal yeast infections
include only the intravaginal imidazoles. It should be noted
thattheseproductscostanaverageoftwotothreetimesmore
thanthevaginalanti-itchcreamsandhomeopathicremedies.
The authors recommend that physicians be directive
in their counseling of patients about which OTC products
women should purchase once diagnosed with a yeast infec-
tion.
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